BioLife Solutions Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -23.0% | -35.9% | +53.2% | +274.4% | +104.6% | +152.5% | +136.0% | -18.8% | -8.3% | -3.2% | +1.6% | |
| – | -42.7% | -33.6% | +114.6% | +278.2% | -35.6% | +374.5% | +9.9% | +9.8% | -12.9% | +23.3% | -8.2% | |
| – | +50.6% | -63.2% | +373.9% | +360.1% | -79.0% | +1,302.9% | -22.8% | -72.2% | +43.5% | +241.9% | -65.4% | |
| – | -61.5% | -63.2% | +373.9% | +360.1% | -79.0% | +1,302.9% | -22.8% | -10.2% | -29.5% | +136.7% | -15.0% | |
| – | +3.1% | +28.4% | -14.5% | +198.2% | +75.5% | +49.8% | +190.0% | +46.2% | -45.0% | -50.9% | -13.3% | |
| – | +90.1% | -4.2% | +5.1% | +90.0% | +216.9% | +4.3% | +144.3% | +23.1% | +24.5% | -33.2% | +3.9% | |
| – | +90.0% | -62.2% | -6.9% | +19.3% | +322.4% | +340.0% | +90.1% | – | – | – | – | |
| – | – | – | – | – | – | +73.8% | +284.5% | +0.0% | +0.0% | -5.5% | -1.8% | |
| – | +76.7% | +0.0% | -100.0% | – | – | +41.2% | +390.0% | -78.9% | -34.1% | -54.8% | -55.5% | |
| – | +17.5% | +89.7% | -56.9% | +1,403.4% | +60.1% | -40.1% | +157.7% | +12.9% | -12.8% | -32.6% | -32.8% | |
| – | +36.8% | -34.3% | +33.5% | +28.2% | +295.5% | +103.1% | +174.2% | +4.4% | -5.4% | -22.4% | -29.8% | |
| – | – | – | – | – | – | +111.6% | +118.0% | +28.2% | +56.7% | +64.5% | -41.9% | |
| – | +116.9% | -31.0% | -2.8% | +4.2% | +333.2% | +17.7% | +307.0% | +2.8% | -54.8% | -48.5% | -58.4% | |
| – | – | – | -100.0% | – | – | – | +869.9% | +274.5% | -23.0% | -72.7% | – | |
| – | -27.9% | -62.8% | +218.8% | +45.0% | +467.4% | +147.2% | +132.9% | -23.8% | -7.3% | +3.3% | +6.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +16.6% | +3.8% | +4.9% | +22.6% | +19.7% | +40.3% | +41.0% | +10.3% | +2.9% | +5.4% | +5.6% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.